CRTAC1 and COVID-19: In a mass spectrometric study conducted early in the COVID‐19 pandemic, we found decreases in plasma cartilage acidic protein 1 (CRTAC1) as measured by label‐free quantification (IBAQ) in a cohort of patients with COVID‐19 and deteriorating respiratory status (Overmyer et al., 2021).